|
業務類別
|
-- |
|
業務概覽
|
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor. |
| 公司地址
| 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020 |
| 電話號碼
| +972 39148213 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tevapharm.com |
| 員工數量
| 33950 |
| Mr. Richard D. Francis |
Director, President and Chief Executive Officer |
美元 1.60M |
03/02/2026 |
| Mr. Evan Lippman |
Executive Vice President, Business Development |
-- |
09/04/2025 |
| Mr. Eli Kalif |
Executive Vice President and Chief Financial Officer |
美元 856.49K |
03/02/2026 |
| Mr. Richard Daniell |
Executive Vice President, European Commercial |
美元 836.75K |
09/04/2025 |
| Mr. Amir Weiss |
Senior Vice President and Chief Accounting Officer |
-- |
03/02/2026 |
| Mr. Mark Sabag |
Executive Vice President, International Markets Commercial |
-- |
09/04/2025 |
| Ms. Christine Fox |
Executive Vice President, U.S. Commercial |
美元 800.00K |
09/04/2025 |
| Dr. Eric A Hughes, M.D.,PhD |
Executive Vice President, Global Research and Development and Chief Medical Officer |
美元 753.85K |
09/04/2025 |
| Mr. David R. McAvoy |
Executive Vice President and Chief Legal Officer |
-- |
09/04/2025 |
| Mr. Placid Jover |
Executive Vice President and Chief Human Resources Officer |
-- |
09/04/2025 |
| Mr. Matthew Shields |
Executive Vice President, Global Operations |
-- |
09/04/2025 |
|
|
| Mr. Richard D. Francis |
Director, President and Chief Executive Officer |
03/02/2026 |
| Professor Ronit Satchi-Fainaro |
Independent Director |
03/02/2026 |
| Mr. Roberto A. Mignone |
Independent Director |
03/02/2026 |
| Dr. Tal Zaks, M.D.,PhD |
Independent Director |
03/02/2026 |
| Dr. Perry D. Nisen |
Independent Director |
03/02/2026 |
| Ms. Janet S. Vergis |
Independent Director |
03/02/2026 |
| Ms. Rosemary A. Crane, M.B.A. |
Independent Director |
03/02/2026 |
| Mr. Chen Lichtenstein |
Independent Director |
03/02/2026 |
| Dr. Sol J. Barer,PhD |
Chairman of the Board |
03/02/2026 |
| Mr. Gerald M. Lieberman |
Independent Director |
03/02/2026 |
| Professor Varda Shalev |
Independent Director |
03/02/2026 |
| Mr. Amir Elstein |
Independent Director |
03/02/2026 |
|
|
|
|
